Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients

Explore this paper's citation graph

Summary

Examination of the oral and gut microbiome of melanoma patients undergoing anti-programmed cell death 1 protein (PD-1) immunotherapy suggested enhanced systemic and antitumor immunity in responding patients with a favorable gut microbiome as well as in germ-free mice receiving fecal transplants from responding patients.

Type
article
Published
2017-11-02
Cited by
4,304
References
79
Access
Open access

Keywords

Microbiome, Immunotherapy, Melanoma, Gut microbiome, Tumor immunology

References

Cited by

Related papers